title: [Severe hypocalcemia after treatment with diphosphonates and aminoglycosides].
authors.forename: P Y
authors.initials: PY
authors.lastname: Bondiau
authors.forename: F
authors.initials: F
authors.lastname: Peyrade
authors.forename: A
authors.initials: A
authors.lastname: Creisson
authors.forename: X
authors.initials: X
authors.lastname: Pivot
authors.forename: J L
authors.initials: JL
authors.lastname: Lagrange
authors.forename: A
authors.initials: A
authors.lastname: Thyss
mesh_terms: D000583:Amikacin / Q000009:adverse effects* / Q000627:therapeutic use; D004002:Clodronic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D008088:Listeriosis / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
chemical_list: D004002:Clodronic Acid; D000583:Amikacin
vernacular_title: Hypocalcémie sévère après traitement par diphosphonates et aminoglycosides.